Literature DB >> 26458755

The practical management of testosterone deficiency in men.

Antonio Aversa1, Abraham Morgentaler2.   

Abstract

Despite increased global interest in testosterone deficiency in men and its treatment with testosterone therapy, practical aspects of care remain confusing to many practitioners. Testosterone deficiency can result from testicular dysfunction (primary hypogonadism) or hypothalamic-pituitary dysfunction (secondary hypogonadism), and be congenital or acquired. Sexual and nonsexual symptoms of testosterone deficiency can negatively affect quality of life and cause considerable general health concerns. Investigation of testosterone deficiency should be undertaken in men with symptoms of reduced libido, erectile dysfunction, depression, fatigue, poor concentration, and poor memory. Total and free testosterone are the most frequently used tests and evaluating serum concentrations of luteinizing hormone aids determination of primary versus secondary testosterone deficiency. Multiple formulations of testosterone therapy are available, but symptomatic benefits might not manifest for several weeks to many months; long-acting formulations are convenient and improve compliance. Concerns regarding cardiovascular and prostate cancer risks are not supported by current evidence, monitoring during therapy is mandatory. On balance, testosterone therapy can be considered a safe and effective treatment for testosterone deficiency.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26458755     DOI: 10.1038/nrurol.2015.238

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN: 1759-4812            Impact factor:   14.432


  144 in total

1.  Effects of testosterone undecanoate replacement and withdrawal on cardio-metabolic, hormonal and body composition outcomes in severely obese hypogonadal men: a pilot study.

Authors:  D Francomano; R Bruzziches; G Barbaro; A Lenzi; A Aversa
Journal:  J Endocrinol Invest       Date:  2014-03-18       Impact factor: 4.256

Review 2.  Androgens and cardiovascular disease.

Authors:  Bu B Yeap
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2010-06       Impact factor: 3.243

Review 3.  Free testosterone: clinical utility and important analytical aspects of measurement.

Authors:  Jennifer L Shea; Pui-Yuen Wong; Yu Chen
Journal:  Adv Clin Chem       Date:  2014       Impact factor: 5.394

4.  Intramuscular testosterone undecanoate: pharmacokinetic aspects of a novel testosterone formulation during long-term treatment of men with hypogonadism.

Authors:  M Schubert; T Minnemann; D Hübler; D Rouskova; A Christoph; M Oettel; M Ernst; U Mellinger; W Krone; F Jockenhövel
Journal:  J Clin Endocrinol Metab       Date:  2004-11       Impact factor: 5.958

5.  Correlates of low testosterone and symptomatic androgen deficiency in a population-based sample.

Authors:  Susan A Hall; Gretchen R Esche; Andre B Araujo; Thomas G Travison; Richard V Clark; Rachel E Williams; John B McKinlay
Journal:  J Clin Endocrinol Metab       Date:  2008-07-29       Impact factor: 5.958

6.  Low testosterone and anaemia in men with type 2 diabetes.

Authors:  Mathis Grossmann; Sianna Panagiotopolous; Ken Sharpe; Richard J MacIsaac; Sophie Clarke; Jeffrey D Zajac; George Jerums; Merlin C Thomas
Journal:  Clin Endocrinol (Oxf)       Date:  2008-08-13       Impact factor: 3.478

7.  Treatment of testosterone-induced gynecomastia with the aromatase inhibitor, anastrozole.

Authors:  E L Rhoden; A Morgentaler
Journal:  Int J Impot Res       Date:  2004-02       Impact factor: 2.896

Review 8.  Topical testosterone supplementation for the treatment of male hypogonadism.

Authors:  Katrina A Abadilla; Adrian S Dobs
Journal:  Drugs       Date:  2012-08-20       Impact factor: 9.546

9.  Testosterone replacement in hypogonadal men with type 2 diabetes and/or metabolic syndrome (the TIMES2 study).

Authors:  T Hugh Jones; Stefan Arver; Hermann M Behre; Jacques Buvat; Eric Meuleman; Ignacio Moncada; Antonio Martin Morales; Maurizio Volterrani; Ann Yellowlees; Julian D Howell; Kevin S Channer
Journal:  Diabetes Care       Date:  2011-03-08       Impact factor: 19.112

10.  Long-term testosterone therapy in hypogonadal men ameliorates elements of the metabolic syndrome: an observational, long-term registry study.

Authors:  A M Traish; A Haider; G Doros; F Saad
Journal:  Int J Clin Pract       Date:  2013-10-15       Impact factor: 2.503

View more
  12 in total

1.  Andrology: Testosterone reference ranges and diagnosis of testosterone deficiency.

Authors:  Abraham Morgentaler
Journal:  Nat Rev Urol       Date:  2017-03-07       Impact factor: 14.432

Review 2.  Oxidation-reduction potential of semen: what is its role in the treatment of male infertility?

Authors:  Ashok Agarwal; Shubhadeep Roychoudhury; Kimberly B Bjugstad; Chak-Lam Cho
Journal:  Ther Adv Urol       Date:  2016-06-28

3.  Testosterone in renal transplant patients: effect on body composition and clinical parameters.

Authors:  Danilo Lofaro; Anna Perri; Antonio Aversa; Benedetta Aquino; Martina Bonofiglio; Antonella La Russa; Maria Giovanna Settino; Francesca Leone; Alessandro Ilacqua; Filomena Armentano; Donatella Vizza; Simona Lupinacci; Giuseppina Toteda; Renzo Bonofiglio
Journal:  J Nephrol       Date:  2018-07-17       Impact factor: 3.902

4.  Sexual Dysfunction in Type 2 Diabetes at Diagnosis: Progression over Time and Drug and Non-Drug Correlated Factors.

Authors:  Giovanni Corona; Carlo B Giorda; Domenico Cucinotta; Piero Guida; Elisa Nada
Journal:  PLoS One       Date:  2016-10-05       Impact factor: 3.240

5.  Variation in Practice Pattern of Male Hypogonadism: A Comparative Analysis of Primary Care, Urology, Endocrinology, and HIV Specialists.

Authors:  Yash S Khandwala; Omer A Raheem; Mir Amaan Ali; Tung-Chin Hsieh
Journal:  Am J Mens Health       Date:  2017-11-28

6.  Testosterone Deficiency, Weakness, and Multimorbidity in Men.

Authors:  Mark D Peterson; Aleksandr Belakovskiy; Ryan McGrath; Joshua F Yarrow
Journal:  Sci Rep       Date:  2018-04-12       Impact factor: 4.379

Review 7.  Hypogonadism in Exercising Males: Dysfunction or Adaptive-Regulatory Adjustment?

Authors:  Anthony C Hackney
Journal:  Front Endocrinol (Lausanne)       Date:  2020-01-31       Impact factor: 5.555

8.  Genetics of Sex Hormone-Binding Globulin and Testosterone Levels in Fertile and Infertile Men of Reproductive Age.

Authors:  Marina Grigorova; Margus Punab; Olev Poolamets; Mart Adler; Vladimir Vihljajev; Maris Laan
Journal:  J Endocr Soc       Date:  2017-04-11

9.  A Content Analysis of Testosterone Websites: Sex, Muscle, and Male Age-Related Thematic Differences.

Authors:  Nicholas Ivanov; Jimmy Vuong; Peter B Gray
Journal:  Am J Mens Health       Date:  2017-10-13

10.  Low lean mass is associated with lower urinary tract symptoms in US men from the 2005-2006 national health and nutrition examination survey dataset.

Authors:  Zheng Qin; Junjie Zhao; Jiameng Li; Qinbo Yang; Jiwen Geng; Ruoxi Liao; Baihai Su
Journal:  Aging (Albany NY)       Date:  2021-09-02       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.